Skip to content
← Back to this collection

PUBLICATIONS · 27269950

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Aug 1
First author
Pieters R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pieters R
      type
      Author
    2. name
      de Groot-Kruseman H
      type
      Author
    3. name
      Van der Velden V
      type
      Author
    4. name
      Fiocco M
      type
      Author
    5. name
      van den Berg H
      type
      Author
    6. name
      de Bont E
      type
      Author
    7. name
      Egeler RM
      type
      Author
    8. name
      Hoogerbrugge P
      type
      Author
    9. name
      Kaspers G
      type
      Author
    10. name
      Van der Schoot E
      type
      Author
    11. name
      De Haas V
      type
      Author
    12. name
      Van Dongen J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pieters R
      type
      Author
    2. name
      de Groot-Kruseman H
      type
      Author
    3. name
      Van der Velden V
      type
      Author
    4. name
      Fiocco M
      type
      Author
    5. name
      van den Berg H
      type
      Author
    6. name
      de Bont E
      type
      Author
    7. name
      Egeler RM
      type
      Author
    8. name
      Hoogerbrugge P
      type
      Author
    9. name
      Kaspers G
      type
      Author
    10. name
      Van der Schoot E
      type
      Author
    11. name
      De Haas V
      type
      Author
    12. name
      Van Dongen J
      type
      Author
    bibliography ids
    1. nci-bib-ba4bf46d0d1176d56787fd47
    book metadata
    content sha256
    6cfafb0703cf787b9881e014f7f2b02cfd11a9c678f775c72b7fb8045f9cf276
    document type
    citation
    dois
    1. 10.1200/JCO.2015.64.6364
    electronic publication date
    display
    2016 Jun 6
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27269950
    immutable id
    pubmed:27269950@6cfafb0703cf787b9881e014f7f2b02cfd11a9c678f775c72b7fb8045f9cf276
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    22
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2591-601
    volume
    34
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27269950
      provenance
      batch id
      fe5a46c92522c34737e8
      provider
      NCBI PubMed ESummary
      record sha256
      420555cbfda6d1e9a7dc29822881df2aad2b9b40220e88b0e2b29b3641d3a75b
      response sha256
      2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
      retrieved at
      2026-09-09T23:47:17.939307+00:00
      publication date
      display
      2016 Aug 1
      precision
      day
      year
      2016
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27269950/
      title
      Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

      Preserved source evidence · Not medical advice